Case: 56-Year-Old Man With Asymptomatic Relapsed Multiple Myeloma
History:
- In 2015, at the age of 53, an African-American man was diagnosed with multiple myeloma; R-ISS stage I
- Patient was treated with bortezomib + lenalidomide + dexamethasone (VRd) for 4 cycles, followed by ASCT
- Patient achieved a VGPR
- Received lenalidomide maintenance for 2 years
September 2018
- On routine follow-up, no clinical symptoms observed
- Imaging: stable disease
- Laboratory results:
- Hb, 11.3 g/dL
- Ca2+9.2 mg/dL
- Creatinine, 0.8 mg/dL
- M-protein:
- June: 1.2 g/dL
- July: 1.4 g/dL
- August: 1.7 g/dL
- Cytogenetics/FISH: no adverse cytogenetics
- ECOG PS: 0
- Patient was started on ixazomib + lenalidomide + dexamethasone (IRd)